SG11201901983PA - Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole - Google Patents
Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrroleInfo
- Publication number
- SG11201901983PA SG11201901983PA SG11201901983PA SG11201901983PA SG11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA
- Authority
- SG
- Singapore
- Prior art keywords
- basel
- roche
- group
- international
- grenzacherstrasse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111101111 0 1110101011111 011101 0 0111111111111111111111111111111111111110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/046428 Al 15 March 2018 (15.03.2018) WI P0 I P C T (51) International Patent Classification: strasse 124, 4070 Basel (CH). MURI, Dieter; c/o F. Hoff- C07D 471/04 (2006.01) mann-La Roche AG, Grenzacherstrasse 124, 4070 Basel (21) International Application Number: (CH). PCT/EP2017/072062 (74) Agent: POPPE, Regina; Grenzacherstrasse 124, 4070 (22) International Filing Date: Basel (CH). 04 September 2017 (04.09.2017) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (30) Priority Data: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 16187960.6 09 September 2016 (09.09.2016) EP HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (71) Applicant (for all designated States except US): F. HOFF- MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, MANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 124, 4070 Basel (CH). SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for US only): HOFFMANN-LA ROCHE INC. [US/US]; Overlook at Great Notch, 150 Clove Road, (84) Designated States (unless otherwise indicated, for every _ 8th Floor, Suite 8 - Legal Department, Little Falls, New Jer- kind of regional protection available): ARIPO (BW, GH, sey 07424 (US). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, — (72) Inventors: BARTELS, Bjoern; c/o F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel (CH). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fk FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, _ — CUENI, Philipp; c/o F. Hoffmann-La Roche AG, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, Grenzacherstrasse 124, 4070 Basel (CH). KOERNER, Matthias; c/o F. Hoffmann-La Roche AG, Grenzacher- = _ = _ Title: PROCESS FOR PREPARATION OF 2-(6-NITROPYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B;3',4'-D]PYRROLE = (54) = = (57) : The present invention relates to a process for preparation of the compound — of formula (I) which processes comprise: a) coupling a compound of formula (2), wherein a / \ — = — 1 p leaving group 0-502-R is selected from the triflate group, the tosylate group, the mesylate ,,, N - / N ' - group, the besylate group, the nosylate group or the brosylate group, with a suitable boronic o I acid, a trifluoroborate or a boronic acid ester under argon condition and in the presence of a = = catalyst and a base in a suitable solvent and then isolating the product as an acid addition salt to afford the compound of formula (Ia) and b) converting the acid addition salt of formula (Ia) wherein the acid HX comprises suitable organic or inorganic acids into the compound of = — \ formula (I) by treatment with at least a stoichiometric equivalent of a suitable base. = N N O' S°2-R = H 2, = = = / \ o N N. N N 0 11 x HX Ia GC ei ii- \ . ____ 0 ,-.... N N N+ N H 0 I 11 ei C [Continued on next page] WO 2018/046428 Al O II TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3))
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16187960 | 2016-09-09 | ||
PCT/EP2017/072062 WO2018046428A1 (en) | 2016-09-09 | 2017-09-04 | Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201901983PA true SG11201901983PA (en) | 2019-04-29 |
Family
ID=56936288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201901983PA SG11201901983PA (en) | 2016-09-09 | 2017-09-04 | Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole |
Country Status (18)
Country | Link |
---|---|
US (1) | US11306093B2 (en) |
EP (1) | EP3510031B1 (en) |
JP (1) | JP6997769B2 (en) |
KR (1) | KR102502701B1 (en) |
CN (1) | CN109689653B (en) |
AR (1) | AR109586A1 (en) |
AU (1) | AU2017324297B2 (en) |
BR (1) | BR112019004091B1 (en) |
CA (1) | CA3035624A1 (en) |
ES (1) | ES2847903T3 (en) |
HR (1) | HRP20210145T1 (en) |
IL (1) | IL265013B (en) |
MX (1) | MX2019002362A (en) |
PL (1) | PL3510031T3 (en) |
SG (1) | SG11201901983PA (en) |
SI (1) | SI3510031T1 (en) |
TW (1) | TWI753009B (en) |
WO (1) | WO2018046428A1 (en) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044152A1 (en) * | 2003-05-09 | 2005-08-24 | Bayer Corp | RENTAL DERIVATIVES, METHOD OF PREPARATION AND USE FOR THE TREATMENT OF OBESITY |
FR2876377B1 (en) | 2004-10-11 | 2007-03-16 | Univ Claude Bernard Lyon | NOVEL 9H-PYRIDO [2,3-B] INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS |
US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
PL2247558T5 (en) | 2008-02-14 | 2024-10-14 | Eli Lilly And Company | Novel imaging agents for detecting neurological dysfunction |
EP2324024B1 (en) | 2008-06-11 | 2012-09-26 | Genentech, Inc. | Diazacarbazoles and methods of use |
JP2011529086A (en) | 2008-07-24 | 2011-12-01 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | Contrast agents useful for identifying AD lesions |
US20100056491A1 (en) * | 2008-08-29 | 2010-03-04 | Memory Pharmaceuticals Corporation | 4'-amino cyclic compounds having 5-ht6 receptor affinity |
US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
EP2411057B1 (en) | 2009-03-23 | 2020-05-06 | Eli Lilly and Company | Imaging agents for detecting neurological disorders |
US20110183938A1 (en) | 2009-12-16 | 2011-07-28 | Genentech, Inc. | 1,7-diazacarbazoles and methods of use |
US20150368244A1 (en) | 2011-01-31 | 2015-12-24 | Genentech, Inc. | Diazacarbazoles and methods of use |
MX2013015147A (en) | 2011-07-05 | 2014-03-27 | Vertex Pharma | Processes and intermediates for producing azaindoles. |
JP6034005B2 (en) | 2011-08-03 | 2016-11-30 | 出光興産株式会社 | Biscarbazole derivative and organic electroluminescence device using the same |
PL3055308T3 (en) | 2013-10-08 | 2018-03-30 | F.Hoffmann-La Roche Ag | Diazacarbazole derivatives as tau-pet-ligands |
MX2017009505A (en) * | 2015-02-02 | 2017-11-02 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives. |
EP3347363B1 (en) * | 2015-09-09 | 2020-01-01 | H. Hoffnabb-La Roche Ag | N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease |
-
2017
- 2017-09-04 SG SG11201901983PA patent/SG11201901983PA/en unknown
- 2017-09-04 CA CA3035624A patent/CA3035624A1/en active Pending
- 2017-09-04 EP EP17768700.1A patent/EP3510031B1/en active Active
- 2017-09-04 AU AU2017324297A patent/AU2017324297B2/en active Active
- 2017-09-04 BR BR112019004091-9A patent/BR112019004091B1/en active IP Right Grant
- 2017-09-04 CN CN201780054464.2A patent/CN109689653B/en active Active
- 2017-09-04 ES ES17768700T patent/ES2847903T3/en active Active
- 2017-09-04 MX MX2019002362A patent/MX2019002362A/en active IP Right Grant
- 2017-09-04 PL PL17768700T patent/PL3510031T3/en unknown
- 2017-09-04 KR KR1020197008785A patent/KR102502701B1/en active IP Right Grant
- 2017-09-04 WO PCT/EP2017/072062 patent/WO2018046428A1/en unknown
- 2017-09-04 JP JP2019513417A patent/JP6997769B2/en active Active
- 2017-09-04 SI SI201730610T patent/SI3510031T1/en unknown
- 2017-09-08 AR ARP170102478A patent/AR109586A1/en active IP Right Grant
- 2017-09-08 TW TW106130720A patent/TWI753009B/en active
-
2019
- 2019-02-24 IL IL265013A patent/IL265013B/en unknown
- 2019-03-06 US US16/294,627 patent/US11306093B2/en active Active
-
2021
- 2021-01-28 HR HRP20210145TT patent/HRP20210145T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2017324297A1 (en) | 2019-03-14 |
US11306093B2 (en) | 2022-04-19 |
MX2019002362A (en) | 2019-06-17 |
TWI753009B (en) | 2022-01-21 |
ES2847903T3 (en) | 2021-08-04 |
SI3510031T1 (en) | 2021-03-31 |
EP3510031A1 (en) | 2019-07-17 |
HRP20210145T1 (en) | 2021-03-05 |
AR109586A1 (en) | 2018-12-26 |
JP6997769B2 (en) | 2022-02-10 |
EP3510031B1 (en) | 2020-12-02 |
BR112019004091B1 (en) | 2023-02-14 |
US20190300529A1 (en) | 2019-10-03 |
CN109689653A (en) | 2019-04-26 |
CN109689653B (en) | 2022-04-12 |
PL3510031T3 (en) | 2021-05-31 |
KR20190044648A (en) | 2019-04-30 |
AU2017324297B2 (en) | 2021-08-05 |
JP2019529401A (en) | 2019-10-17 |
WO2018046428A1 (en) | 2018-03-15 |
TW201811787A (en) | 2018-04-01 |
CA3035624A1 (en) | 2018-03-15 |
BR112019004091A2 (en) | 2019-05-28 |
KR102502701B1 (en) | 2023-02-23 |
IL265013B (en) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201901700UA (en) | Biaryl compounds useful as immunomodulators | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
SG11201909433XA (en) | Targeted compositions | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
SG11201903582UA (en) | Settlement method, entrance control method, and apparatus | |
SG11201805166PA (en) | Light-mediated polymerase chain reaction amplification and product detection system and methods of use | |
SG11201906844RA (en) | Biometric feature database establishing method and apparatus | |
SG11201811336TA (en) | Method for producing an electrode catalyst from a perovskite metal oxide | |
SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
SG11201805115PA (en) | Detection and quantification of target nucleic acid sequence of a microorganism | |
SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
SG11201807038UA (en) | Rodents having a humanized tmprss gene | |
SG11201807382RA (en) | A single- or multiple component composition for producing a hydrogel | |
SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
SG11201807775SA (en) | Aqueous polymer dispersions, a method for their preparation and the use thereof as pour-point depressants for crude oil, petroleum, and petroleum products | |
SG11201803979PA (en) | Sulfur-containing compounds as solvents | |
SG11201805263TA (en) | Compositions and methods for detecting and treating esophageal cancer | |
SG11201908605XA (en) | Antifouling article |